KRISTV.com
CORPUS CHRISTI, TEXAS | CONTINUOUS NEWS COVERAGE
Powered by
National News
Pharmaceutical Firm Settles Lawsuit Over Pregnancy Drug
Posted: Jan 9, 2013 2:13 PM by Associated Press
BOSTON (AP) - A lawyer for four sisters who claimed their breast cancer was caused by a drug their mother took during pregnancy in the 1950s says they have reached a settlement with a pharmaceutical company.
Attorney Julie Oliver-Zhang says the deal with Indianapolis-based Eli Lilly and Co. was for an undisclosed amount. She says it was reached Wednesday on the second day of a trial in federal court in Boston.
Eli Lilly didn't immediately respond to a message seeing comment.
A lawyer for the sisters said in trial openings Tuesday that Eli Lilly failed to test the drug's effect on fetuses before promoting it as a way to prevent miscarriages.
A lawyer for Eli Lilly had said there's no evidence the drug causes breast cancer in the daughters of women who took it, or that the mother of the four sisters took it.
The sisters' case was the first to go to trial out of scores of similar claims filed in Boston and around the country.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
Video On Demand
Submit News
Do you have a tip, information about a breaking news story, or a story idea for 6 Investigates? Contact the KRIS 6 News Desk at 361-884-6666 or send us an email.
Most Popular
KRISTV.COM is Social!
Click the icons above to receive News, Weather, and Sports alerts from KRISTV.COM!
Inside KRISTV.COM
 |
Photo Central Look at photos and videos and share them! |
 |
Desktop Weather Current forecast, hurricane info, and much more! |
 |
KRISTV.COM Mobile Website Get KRISTV.com on your mobile or PDA! |
 |
KRISTV.COM Mobile Apps Get our mobile apps on your mobile or PDA! |
 |
Texas Lottery See the latest winning numbers! |
 |
6 News Team Read about your favorite KRIS-TV personalities! |
 |
FCC Online Public File FCC Public File of Records, Reports, and more |
Comments